共 7 条
An update on prospective audit of rivaroxaban as prophylaxis and treatment during myeloma therapy with immunomodulatory drugs (IMiDs) at East Kent Hospitals University NHS Foundation Trust
被引:0
作者:
Roughley, C. A.
[1
]
Capomir, M.
[2
]
Lindsay, J.
[1
]
Pocock, C.
[1
]
Ratnayake, V.
[1
]
Saied, K.
[1
]
Evans, G.
[3
]
机构:
[1] East Kent Hosp Univ NHS Fdn Trust, Dept Clin Haematol, Canterbury, Kent, England
[2] East Kent Hosp Univ NHS Fdn Trust, Dept Pharm, Canterbury, Kent, England
[3] East Kent Hosp Univ NHS Fdn Trust, Kent Haemophilia & Thrombosis Ctr, Canterbury, Kent, England
关键词:
D O I:
暂无
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
248
引用
收藏
页码:103 / 103
页数:1
相关论文